SCHEMBL26075357

SCHEMBL26075357

CCCCCOc1ccc(-c2ccc(-c3cc(C=O)c4cc(C)ccc4n3)cc2F)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 3/20 0.42
▸ PTPN11 Q06124 3/20 0.39
▸ MAPT P10636 2/20 0.39
▸ DHODH Q02127 2/20 0.39
▸ PDE10A Q9Y233 1/20 0.38
▸ RARA P10276 1/20 0.37
▸ RARB P10826 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ HPGD P15428 3/20 0.37
▸ THRB P10828 2/20 0.37
▸ PLK1 P53350 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ HSP90AA1 P07900 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ XDH P47989 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26075365 0.99 PLA2G2A (0.41) PLA2G2APTPN11MAPTDHODHPDE10A
SCHEMBL26075360 0.99 PLA2G2A (0.41) PLA2G2APTPN11MAPTDHODHPDE10A
SCHEMBL26075362 0.99 PLA2G2A (0.41) PLA2G2APTPN11MAPTDHODHPDE10A
SCHEMBL26075354 0.99 PLA2G2A (0.41) PLA2G2APTPN11MAPTDHODHPDE10A
SCHEMBL26075350 0.89 PLA2G2A (0.44) PLA2G2AMAPTDHODHPDE10ARARA
SCHEMBL26075374 0.88 TP53 (0.36) PLA2G2AMAPTDHODHPDE10AALDH1A1
SCHEMBL26075905 0.86 DHODH (0.56) PLA2G2APTPN11MAPTDHODHPDE10A
SCHEMBL26075378 0.86 XDH (0.39) MAPTDHODHALDH1A1HPGDTHRB
SCHEMBL26075352 0.85 DHODH (0.45) PLA2G2ADHODHPDE10A
SCHEMBL26075337 0.85 MAPT (0.49) PLA2G2AMAPTDHODHALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD PLA2G2A 1679/4885PTPN11 3866/4885MAPT 2689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback